|

SGLT2 inhibitors (Dapagliflozin and Empagliflozin) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • Samsung Medical Center1

Indications

  • DC Cardioversion1
  • SGLT2 Inhibitor1
  • Heart Disease1
  • Atrial Fibrillation1

Other1 trial

Clinical Impact of SGLT2 Inhibitor After DC Cardioversion in Persistent AF With HFpEF
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.